HEADER SUGAR BINDING PROTEIN 30-AUG-11 2LIQ TITLE SOLUTION STRUCTURE OF CCL2 IN COMPLEX WITH GLYCAN COMPND MOL_ID: 1; COMPND 2 MOLECULE: CCL2 LECTIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: COPRINOPSIS CINEREA; SOURCE 3 ORGANISM_COMMON: INKY CAP FUNGUS; SOURCE 4 ORGANISM_TAXID: 5346; SOURCE 5 GENE: CCL2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET22 KEYWDS CARBOHYDRATE RECOGNITION, SUGAR BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.SCHUBERT,S.BLEULER-MARTINEZ,M.A.WALTI,P.EGLOFF,M.AEBI,M.KUENZLER, AUTHOR 2 F.H.-T.ALLAIN REVDAT 5 15-MAY-24 2LIQ 1 REMARK REVDAT 4 18-AUG-21 2LIQ 1 REMARK HETSYN REVDAT 3 29-JUL-20 2LIQ 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 15-NOV-17 2LIQ 1 REMARK REVDAT 1 06-JUN-12 2LIQ 0 JRNL AUTH M.SCHUBERT,S.BLEULER-MARTINEZ,A.BUTSCHI,M.A.WALTI,P.EGLOFF, JRNL AUTH 2 K.STUTZ,S.YAN,I.B.WILSON,M.O.HENGARTNER,M.AEBI,F.H.ALLAIN, JRNL AUTH 3 M.KUNZLER JRNL TITL PLASTICITY OF THE BETA-TREFOIL PROTEIN FOLD IN THE JRNL TITL 2 RECOGNITION AND CONTROL OF INVERTEBRATE PREDATORS AND JRNL TITL 3 PARASITES BY A FUNGAL DEFENCE SYSTEM JRNL REF PLOS PATHOG. V. 8 02706 2012 JRNL REFN ISSN 1553-7366 JRNL PMID 22615566 JRNL DOI 10.1371/JOURNAL.PPAT.1002706 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : AMBER REMARK 3 AUTHORS : CASE, DARDEN, CHEATHAM, III, SIMMERLING, WANG, REMARK 3 DUKE, LUO, AND KOLLMAN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LIQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1000102432. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 310 REMARK 210 PH : 4.7 REMARK 210 IONIC STRENGTH : 150 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM [U-100% 13C; U-100% 15N] REMARK 210 CCL2, 1 MM SUGAR (3-MER), 50 MM REMARK 210 POTASSIUM PHOSPHATE, 100 MM REMARK 210 SODIUM CHLORIDE, ~41 MM [U-100% REMARK 210 2H] ACETIC ACID, 90% H2O/10% D2O; REMARK 210 1 MM [U-100% 13C; U-100% 15N] REMARK 210 CCL2, 1 MM SUGAR (3-MER), 50 MM REMARK 210 POTASSIUM PHOSPHATE, 100 MM REMARK 210 SODIUM CHLORIDE, ~41 MM [U-100% REMARK 210 2H] ACETIC ACID, 100% D2O; 1 MM REMARK 210 [U-100% 15N] CCL2, 1 MM SUGAR (3- REMARK 210 MER), 50 MM POTASSIUM PHOSPHATE, REMARK 210 100 MM SODIUM CHLORIDE, ~41 MM REMARK 210 [U-100% 2H] ACETIC ACID, 90% H2O/ REMARK 210 10% D2O; 1 MM [U-100% 15N] CCL2, REMARK 210 1 MM SUGAR (3-MER), 50 MM REMARK 210 POTASSIUM PHOSPHATE, 100 MM REMARK 210 SODIUM CHLORIDE, ~41 MM [U-100% REMARK 210 2H] ACETIC ACID, 100% D2O; 1 MM REMARK 210 [U-1% 13C; U-100% 15N] CCL2, 1 REMARK 210 MM SUGAR (3-MER), 50 MM REMARK 210 POTASSIUM PHOSPHATE, 100 MM REMARK 210 SODIUM CHLORIDE, 41 MM [U-100% REMARK 210 2H] ACETIC ACID 95%H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 15N-HSQC; 2D REMARK 210 NOESY; 3D 15N EDITED NOESY; 2D REMARK 210 15N F1-FILTERED,F2-FILTERED REMARK 210 NOESY; 2D TOCSY; 2D 13C-HSQC (AT REMARK 210 NATURAL ABUNDANCE); 2D 15N-HSQC REMARK 210 (FOR H/D EXCHANGE); 2D 13C-HSQC REMARK 210 FOR ALIPHATIC REGION; 2D 13C- REMARK 210 HSQC FOR AROMATIC REGION; 3D REMARK 210 13CEDITED-NOESY FOR ALIPHATIC REMARK 210 REGION; 2D 13CEDITED NOESY FOR REMARK 210 AROMATIC REGION; 3D HNCA; 3D REMARK 210 HNCACB; 3D HNCO; 3D HCCH-COSY; REMARK 210 2D 13C F1-FILTERED TOCSY; 2D 13C REMARK 210 F1-FILTERED NOESY; 2D 13C F1- REMARK 210 FILTERED, F2-FILTERED NOESY; 3D REMARK 210 13C F1-EDITED, F3-FILTERED NOESY REMARK 210 FOR ALIPHATIC REGION; 3D 13C F1- REMARK 210 EDITED, F3-FILTERED NOESY FOR REMARK 210 AROMATIC REGION; 2D CONSTANT- REMARK 210 TIME 13C-HSQC TO UNAMBIGUOUSLY REMARK 210 ASSIGN THE STEREOCHEMICAL METHYL REMARK 210 GROUPS OF VAL AND LEU REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 750 MHZ; 900 REMARK 210 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, SPARKY, CYANA, TALOS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 300 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 2 ARG A 121 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 4 ARG A 147 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 5 ARG A 121 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 14 ARG A 147 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 15 ARG A 121 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 16 ARG A 121 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 16 ARG A 147 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 17 ARG A 121 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASP A 13 -6.27 -142.92 REMARK 500 1 LEU A 31 -144.55 52.68 REMARK 500 1 SER A 82 55.89 -140.32 REMARK 500 1 ALA A 91 0.73 56.99 REMARK 500 1 ASN A 101 -78.52 -147.00 REMARK 500 1 ASN A 102 14.88 -152.81 REMARK 500 1 SER A 111 -6.84 -57.34 REMARK 500 1 ARG A 121 18.43 54.14 REMARK 500 2 HIS A 3 21.40 -142.88 REMARK 500 2 PRO A 15 154.17 -49.43 REMARK 500 2 ALA A 21 93.58 -67.85 REMARK 500 2 LEU A 31 -142.50 54.40 REMARK 500 2 ASN A 84 6.48 -68.86 REMARK 500 2 ALA A 91 -1.57 55.87 REMARK 500 2 ASN A 101 -92.27 -147.89 REMARK 500 2 ASN A 102 10.79 -144.41 REMARK 500 2 LEU A 107 78.16 -112.18 REMARK 500 2 SER A 111 -6.47 -59.61 REMARK 500 2 ARG A 121 16.29 56.98 REMARK 500 2 PHE A 144 -27.21 -151.42 REMARK 500 3 HIS A 3 10.78 -142.82 REMARK 500 3 ALA A 91 -0.21 56.06 REMARK 500 3 ASN A 101 -82.89 -149.31 REMARK 500 3 ASN A 102 11.55 -149.09 REMARK 500 4 ASP A 13 25.48 -145.68 REMARK 500 4 LEU A 31 -155.97 52.48 REMARK 500 4 TYR A 68 -38.16 -133.34 REMARK 500 4 SER A 82 61.25 -153.76 REMARK 500 4 ALA A 91 -0.31 56.31 REMARK 500 4 PRO A 99 155.09 -48.69 REMARK 500 4 ASN A 101 -108.14 -151.27 REMARK 500 4 ASN A 102 21.03 -149.01 REMARK 500 4 LEU A 107 78.16 -111.54 REMARK 500 4 SER A 111 -8.58 -59.81 REMARK 500 4 PHE A 144 -24.40 -158.06 REMARK 500 5 HIS A 7 -17.99 -147.40 REMARK 500 5 ASP A 13 -25.83 -151.34 REMARK 500 5 ASP A 56 -23.28 -144.69 REMARK 500 5 ALA A 91 0.57 57.78 REMARK 500 5 PRO A 99 153.83 -49.82 REMARK 500 5 ASN A 101 -100.44 -153.83 REMARK 500 5 ASN A 102 24.35 -153.26 REMARK 500 5 PHE A 144 -28.68 -155.56 REMARK 500 5 SER A 145 5.46 -63.66 REMARK 500 6 HIS A 8 19.18 -140.10 REMARK 500 6 ALA A 16 -63.86 -141.30 REMARK 500 6 VAL A 17 -63.75 -144.24 REMARK 500 6 THR A 18 14.98 -170.05 REMARK 500 6 LEU A 31 -136.98 54.79 REMARK 500 6 SER A 82 58.00 -145.57 REMARK 500 REMARK 500 THIS ENTRY HAS 168 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2LIE RELATED DB: PDB REMARK 900 RELATED ID: 17902 RELATED DB: BMRB DBREF 2LIQ A 13 153 UNP B3GA02 B3GA02_COPCI 2 142 SEQADV 2LIQ MET A 1 UNP B3GA02 EXPRESSION TAG SEQADV 2LIQ GLY A 2 UNP B3GA02 EXPRESSION TAG SEQADV 2LIQ HIS A 3 UNP B3GA02 EXPRESSION TAG SEQADV 2LIQ HIS A 4 UNP B3GA02 EXPRESSION TAG SEQADV 2LIQ HIS A 5 UNP B3GA02 EXPRESSION TAG SEQADV 2LIQ HIS A 6 UNP B3GA02 EXPRESSION TAG SEQADV 2LIQ HIS A 7 UNP B3GA02 EXPRESSION TAG SEQADV 2LIQ HIS A 8 UNP B3GA02 EXPRESSION TAG SEQADV 2LIQ HIS A 9 UNP B3GA02 EXPRESSION TAG SEQADV 2LIQ HIS A 10 UNP B3GA02 EXPRESSION TAG SEQADV 2LIQ SER A 11 UNP B3GA02 EXPRESSION TAG SEQADV 2LIQ GLY A 12 UNP B3GA02 EXPRESSION TAG SEQRES 1 A 153 MET GLY HIS HIS HIS HIS HIS HIS HIS HIS SER GLY ASP SEQRES 2 A 153 SER PRO ALA VAL THR LEU SER ALA GLY ASN TYR ILE ILE SEQRES 3 A 153 TYR ASN ARG VAL LEU SER PRO ARG GLY GLU LYS LEU ALA SEQRES 4 A 153 LEU THR TYR PRO GLY ARG GLN ARG THR PRO VAL THR VAL SEQRES 5 A 153 SER PRO LEU ASP GLY SER SER GLU GLN ALA TRP ILE LEU SEQRES 6 A 153 ARG SER TYR ASP SER ASN SER ASN THR TRP THR ILE SER SEQRES 7 A 153 PRO VAL GLY SER PRO ASN SER GLN ILE GLY TRP GLY ALA SEQRES 8 A 153 GLY ASN VAL PRO VAL VAL LEU PRO PRO ASN ASN TYR VAL SEQRES 9 A 153 TRP THR LEU THR LEU THR SER GLY GLY TYR ASN ILE GLN SEQRES 10 A 153 ASP GLY LYS ARG THR VAL SER TRP SER LEU ASN ASN ALA SEQRES 11 A 153 THR ALA GLY GLU GLU VAL SER ILE GLY ALA ASP ALA THR SEQRES 12 A 153 PHE SER GLY ARG TRP VAL ILE GLU LYS VAL HET MAG B 1 31 HET FUC B 2 21 HET NAG B 3 28 HETNAM MAG METHYL 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN MAG BETA-METHYL-N-ACETYL-D-GLUCOSAMINE; METHYL 2-ACETAMIDO- HETSYN 2 MAG 2-DEOXY-BETA-D-GLUCOSIDE; METHYL 2-ACETAMIDO-2-DEOXY- HETSYN 3 MAG D-GLUCOSIDE; METHYL 2-ACETAMIDO-2-DEOXY-GLUCOSIDE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 MAG C9 H17 N O6 FORMUL 2 FUC C6 H12 O5 FORMUL 2 NAG C8 H15 N O6 SHEET 1 A 7 GLY A 22 ASN A 28 0 SHEET 2 A 7 TRP A 63 SER A 67 -1 O TRP A 63 N TYR A 24 SHEET 3 A 7 THR A 74 PRO A 79 -1 O THR A 76 N ARG A 66 SHEET 4 A 7 TRP A 105 THR A 110 -1 O TRP A 105 N TRP A 75 SHEET 5 A 7 GLY A 113 GLN A 117 -1 O GLN A 117 N THR A 106 SHEET 6 A 7 TRP A 148 LYS A 152 -1 O TRP A 148 N TYR A 114 SHEET 7 A 7 GLY A 22 ASN A 28 -1 N ILE A 25 O GLU A 151 SHEET 1 B 2 LEU A 38 THR A 41 0 SHEET 2 B 2 THR A 51 PRO A 54 -1 O THR A 51 N THR A 41 SHEET 1 C 2 GLN A 86 TRP A 89 0 SHEET 2 C 2 PRO A 95 LEU A 98 -1 O LEU A 98 N GLN A 86 SHEET 1 D 2 SER A 124 SER A 126 0 SHEET 2 D 2 SER A 137 GLY A 139 -1 O GLY A 139 N SER A 124 LINK O3 MAG B 1 C1 FUC B 2 1555 1555 1.47 LINK O4 MAG B 1 C1 NAG B 3 1555 1555 1.47 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1